Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (261-270 of 688) with videos related to

Pageof 69
Sort By:
JAMA|November 9, 2015
Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart FailureLauren B Cooper, Bradley G Hammill, Eric D Peterson, et al.
European Journal of Heart Failure|November 10, 2021
Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCATJoão Pedro Ferreira, Jiankang Liu, Brian L Claggett, et al.
American Heart Journal|March 30, 2002
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)John A Spertus, Joseph Tooley, Phil Jones, et al.
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.
European Journal of Heart Failure|January 10, 2018
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Kevin Duarte, Marc A Pfeffer, et al.
American Journal of Hypertension|July 20, 2023
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD StudyGeorge L Bakris, Y Fred Yang, James M McCabe, et al.
JACC. Basic to Translational Science|August 1, 2018
Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered SolutionDomenic A Sica, Pieter Muntendam, Rene L Myers, et al.
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudyVeronique Regnault, Jérémy Lagrange, Anne Pizard, et al.
European Journal of Heart Failure|October 25, 2016
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
BMC Medicine|June 23, 2012
Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysisPascal Meier, Andreas Indermuehle, Bertram Pitt, et al.
Pageof 69

Showing results (261-270 of 688) with videos related to

Sort By:
Pageof 69
JAMA|November 9, 2015
Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart FailureLauren B Cooper, Bradley G Hammill, Eric D Peterson, et al.
European Journal of Heart Failure|November 10, 2021
Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCATJoão Pedro Ferreira, Jiankang Liu, Brian L Claggett, et al.
American Heart Journal|March 30, 2002
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)John A Spertus, Joseph Tooley, Phil Jones, et al.
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.
European Journal of Heart Failure|January 10, 2018
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Kevin Duarte, Marc A Pfeffer, et al.
American Journal of Hypertension|July 20, 2023
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD StudyGeorge L Bakris, Y Fred Yang, James M McCabe, et al.
JACC. Basic to Translational Science|August 1, 2018
Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered SolutionDomenic A Sica, Pieter Muntendam, Rene L Myers, et al.
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudyVeronique Regnault, Jérémy Lagrange, Anne Pizard, et al.
European Journal of Heart Failure|October 25, 2016
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
BMC Medicine|June 23, 2012
Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysisPascal Meier, Andreas Indermuehle, Bertram Pitt, et al.
Pageof 69